1. Home
  2. HIHO vs DCOY Comparison

HIHO vs DCOY Comparison

Compare HIHO & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

N/A

Current Price

$0.91

Market Cap

4.3M

Sector

Industrials

ML Signal

N/A

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$0.72

Market Cap

4.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIHO
DCOY
Founded
1990
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.7M
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
HIHO
DCOY
Price
$0.91
$0.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
42.6K
159.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
12.97%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.62
52 Week High
$2.21
$1.41

Technical Indicators

Market Signals
Indicator
HIHO
DCOY
Relative Strength Index (RSI) 41.93 45.50
Support Level $0.89 $0.65
Resistance Level $1.21 $0.85
Average True Range (ATR) 0.05 0.07
MACD 0.01 -0.00
Stochastic Oscillator 42.30 13.89

Price Performance

Historical Comparison
HIHO
DCOY

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Share on Social Networks: